Compare · ACCD vs CMLF
ACCD vs CMLF
Side-by-side comparison of Accolade Inc. (ACCD) and CM Life Sciences, Inc. (CMLF): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACCD operates in Consumer Discretionary, while CMLF operates in Finance - the two are in different parts of the market.
- ACCD carries a market cap of $1.18B.
- ACCD has more recent analyst coverage (25 ratings vs 0 for CMLF).
- Company
- Accolade Inc.
- CM Life Sciences, Inc.
- Price
- $7.03+0.00%
- $11.78-5.23%
- Market cap
- $1.18B
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2020
- News (4w)
- 0
- 0
- Recent ratings
- 25
- 0
Accolade Inc.
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Latest ACCD
- Defining Wellness Centers Names Bill Morrison Chief Financial Officer
- SEC Form 15-12G filed by Accolade Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Accolade Inc.
- SEC Form 25-NSE filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- Chief Executive Officer Singh Rajeev returned $10,429,525 worth of shares to the company (1,483,574 units at $7.03), closing all direct ownership in the company (SEC Form 4)
Latest CMLF
- Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
- SEC Form 4 filed by Sherman Rachel E.
- SEC Form 4 filed by Turner Nat
- SEC Form 4 filed by Pellini Michael J
- SEC Form 4 filed by Ruch Joshua
- SEC Form 4 filed by Ryan Jason
- SEC Form 4 filed by Leproust Emily M.
- SEC Form 4 filed by Casdin Eli
- SEC Form 4 filed by Charney Dennis
- SEC Form 424B3 filed by CM Life Sciences, Inc.